Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medical Devices


Interviews

Canada’s top edible cannabis producer eyes further growth

Emerging opportunity in a growing, high-value dermatological market

Press Releases

Doximity, Inc. (DOCS) Investors: June 17, 2024 Filing Deadline in Securities Class Action -...

  May 15, 2024

NeuroMetrix Reports Q1 2024 Business Highlights

  May 15, 2024

Ventripoint Applies for Extension of Non-Brokered Convertible Debenture Private Placement

  May 14, 2024

Aspira Women's Health Reports First Quarter 2024 Financial Results

  May 15, 2024

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024

  May 15, 2024

Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update

  May 15, 2024

Venus Concept Announces First Quarter of Fiscal Year 2024 Financial Results

  May 15, 2024

Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents

  May 15, 2024

Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of...

  May 15, 2024

MediPharm Labs Reports First Quarter Results

  May 15, 2024

Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment...

  May 15, 2024

CloudMD Announces Go-Private Transaction with CPS Capital

  May 15, 2024

Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive

  May 15, 2024

CSE Bulletin: Suspension - TAAT Global Alternatives Inc. (TAAT)

  May 15, 2024

Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM)

  May 15, 2024

TAAT Provides Update on Status of Audited Financial Statements

  May 15, 2024

HEALWELL AI Reports Q1-2024 Financial Results

  May 14, 2024

CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights

  May 15, 2024

CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position

  May 15, 2024

60 Degrees Pharmaceuticals Announces First Quarter 2024 Results

  May 15, 2024

Star Equity Holdings to Release First Quarter 2024 Financial Results on May 20th

  May 15, 2024

Blüm Holdings Inc. Reports First Quarter 2024 Financial Results

  May 15, 2024

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in...

  May 15, 2024

TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for...

  May 15, 2024

AYR Wellness Reports First Quarter 2024 Results

  May 15, 2024

Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution...

  May 15, 2024

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareore...

  May 15, 2024

Microbix Reports Strong Results for Q2 Fiscal 2024

  May 15, 2024

ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update

  May 15, 2024

T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

  May 15, 2024

Canada Added to a Growing List of Countries Regulating Cibus' Gene Editing Technologies Similar...

  May 15, 2024

Humana Ranks 6th Overall in Fair360 National Companies for Diversity

  May 15, 2024

aTyr Pharma to Present Poster Describing Efzofitimod's Mechanism of Action at the American...

  May 15, 2024

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference

  May 15, 2024

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

  May 15, 2024

Trevena Reports First Quarter 2024 Results and Provides Business Update

  May 15, 2024

Bio-Path Holdings Reports First Quarter 2024 Financial Results

  May 15, 2024

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

  May 15, 2024

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...

  May 15, 2024

Yield10 Bioscience Announces First Quarter 2024 Financial Results

  May 15, 2024

Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update

  May 15, 2024

ROSEN, LEADING INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel...

  May 15, 2024

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  May 15, 2024

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and...

  May 15, 2024

GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

  May 15, 2024

Retractable Technologies, Inc. Results for the Period Ended March 31, 2024

  May 15, 2024

Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

  May 15, 2024

Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

  May 15, 2024

Soleno Therapeutics Stands with the Prader-Willi Syndrome Community

  May 15, 2024

CERo Therapeutics, Inc. Provides Corporate Update for Shareholders

  May 15, 2024

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress

  May 15, 2024

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  May 15, 2024

More

Agriculture Building Materials Cannabis Chemicals Coal Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Forest Products Healthcare Industrials Metals & Mining Gold Industrial Metals & Minerals Silver Real Estate Steel Technology Utilities

Companies of Interest

Theralase Technologies Inc.
Nanalysis Scientific Corp.